You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Healthcare-associated infections

Tegaderm CHG securement dressing for vascular access sites in critically ill adults

  • Medical technologies guidance
  • Reference number: MTG25
  • Published:  22 July 2015
  • Last updated:  18 September 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: supporting documents

Table of contents

1. Final Scope

2. Submission of evidence by 3M

3. Assessment Report

4. Addendum to the Assessment Report

5. Correspondence with EAC

6. Factual Check of the assessment report

7. Overview of assessment report

8. Clinical expert advice

 

 

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: scope

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: submission of evidence by 3M

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: assessment report

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: addendum to the assessment report

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: correspondence with EAC

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: factual check of the assessment report

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: overview of assessment report

  • The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: clinical expert advice


This page was last updated: 09 June 2015

Back to top